![PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway | Science Advances PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway | Science Advances](https://www.science.org/cms/10.1126/sciadv.abh2148/asset/e56786c9-d9aa-4ba2-8beb-e2caea049938/assets/images/large/sciadv.abh2148-f1.jpg)
PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway | Science Advances
![Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers](https://www.frontiersin.org/files/MyHome%20Article%20Library/695006/695006_Thumb_400.jpg)
Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis | PLOS ONE
![Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease - Bartl - 2023 - Movement Disorders - Wiley Online Library Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease - Bartl - 2023 - Movement Disorders - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/8bbbb96b-8c14-47b7-8a29-6567c19ea6dc/mds29257-toc-0001-m.jpg?trick=1674156155059)
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease - Bartl - 2023 - Movement Disorders - Wiley Online Library
![Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma | Cancer Cell International | Full Text Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-021-02217-y/MediaObjects/12935_2021_2217_Fig1_HTML.png)
Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma | Cancer Cell International | Full Text
![The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma | SpringerLink The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00262-022-03187-4/MediaObjects/262_2022_3187_Fig1_HTML.png)
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma | SpringerLink
![Pharmacokinetic/Pharmacodynamic Studies in Drug Product Development - Journal of Pharmaceutical Sciences Pharmacokinetic/Pharmacodynamic Studies in Drug Product Development - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/2046422163/2057415956/gr1.jpg)
Pharmacokinetic/Pharmacodynamic Studies in Drug Product Development - Journal of Pharmaceutical Sciences
![IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma](https://pub.mdpi-res.com/ijms/ijms-22-10271/article_deploy/html/images/ijms-22-10271-g001.png?1632469653)
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
![Parkinson's Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson's disease (PD) - MDS Abstracts Parkinson's Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson's disease (PD) - MDS Abstracts](http://www.mdsabstracts.org/wp-content/uploads/2022/09/0650_0914_001225_001.png)
Parkinson's Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson's disease (PD) - MDS Abstracts
![Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION - ScienceDirect Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572821002423-ga1.jpg)
Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXION - ScienceDirect
![A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma | Journal for ImmunoTherapy of Cancer | Full Text A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma | Journal for ImmunoTherapy of Cancer | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs40425-019-0703-0/MediaObjects/40425_2019_703_Fig2_HTML.png)